{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:40:16Z","timestamp":1770730816754,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101099","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:30:11Z","timestamp":1767889811000},"page":"101099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatments and survival outcomes of patients with synchronous and metachronous metastatic bladder cancer: A population-based nationwide cohort study"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1580-1543","authenticated-orcid":false,"given":"Anke","family":"Richters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira D.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard P.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine G.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franchette W.P.J.","family":"van den Berkmortel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja K.H.","family":"Aben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101099_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: a cancer journal for clinicians"},{"key":"10.1016\/j.ctarc.2026.101099_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medsci8010015","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Medical sciences"},{"key":"10.1016\/j.ctarc.2026.101099_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047256","article-title":"Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the \u2018trials within cohorts\u2019 study ProBCI","volume":"11","author":"Richters","year":"2021","journal-title":"BMJ open"},{"key":"10.1016\/j.ctarc.2026.101099_bib0005","series-title":"TNM classification of malignant tumours: 8th edition","author":"Brierley","year":"2017"},{"key":"10.1016\/j.ctarc.2026.101099_bib0006","series-title":"International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3)","author":"Fritz","year":"2000"},{"key":"10.1016\/j.ctarc.2026.101099_bib0007","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41416-023-02543-0","article-title":"Systemic anticancer therapy for urothelial carcinoma: UK oncologists\u2019 perspective","volume":"130","author":"Jones","year":"2024","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.ctarc.2026.101099_bib0008","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/bjc.2015.127","article-title":"Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?","volume":"112","author":"Lobbezoo","year":"2015","journal-title":"British journal of cancer"},{"key":"10.1016\/j.ctarc.2026.101099_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clgc.2023.06.010","article-title":"A SEER-medicare based quality score for patients with metastatic upper tract urothelial carcinoma","volume":"22","author":"Joyce","year":"2024","journal-title":"Clinical Genitourinary Cancer"},{"key":"10.1016\/j.ctarc.2026.101099_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clcc.2013.11.008","article-title":"Colorectal cancer survival: an analysis of patients with metastatic disease synchronous and metachronous with the primary tumor","volume":"13","author":"Kumar","year":"2014","journal-title":"Clinical colorectal cancer"},{"key":"10.1016\/j.ctarc.2026.101099_bib0011","doi-asserted-by":"crossref","DOI":"10.2340\/1651-226X.2025.42985","article-title":"Synchronous metastases from colorectal cancer. Treatment and long-term survival compared to patients with metachronous metastases: a population-based study from Central Norway 2001\u20132015","volume":"64","author":"Storli","year":"2025","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.ctarc.2026.101099_bib0012","doi-asserted-by":"crossref","unstructured":"Hoeh B, Garcia CC, Mattigk A, Sondermann M, Kl\u00fcmper N, Cox A, Hahn O, Vollemaere J, Erdmann K, Schmucker P. (2025) Metastatic renal cell carcinoma: Synchronous vs. metachronous metastatic disease and its impact on cancer control in the IO-combination era\u2014Real world experiences from a multi-institutional cohort. in Urologic Oncology: Seminars and Original Investigations ed.), Elsevier.","DOI":"10.1016\/j.eururo.2025.09.3857"},{"key":"10.1016\/j.ctarc.2026.101099_bib0013","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.euo.2020.01.001","article-title":"Synchronous versus metachronous metastatic disease: impact of time to metastasis on patient outcome\u2014results from the international metastatic renal cell carcinoma database consortium","volume":"3","author":"Donskov","year":"2020","journal-title":"European urology oncology"},{"key":"10.1016\/j.ctarc.2026.101099_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221085557","article-title":"A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma","volume":"14","author":"Pape","year":"2022","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"10.1016\/j.ctarc.2026.101099_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmorw.2025.100153","article-title":"Real-world treatment patterns and survival in patients with synchronous and metachronous metastatic colorectal cancer in the Netherlands","volume":"8","author":"Elferink","year":"2025","journal-title":"ESMO Real World Data and Digital Oncology"},{"key":"10.1016\/j.ctarc.2026.101099_bib0016","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ejso.2012.02.187","article-title":"External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder","volume":"38","author":"Nuhn","year":"2012","journal-title":"European Journal of Surgical Oncology (EJSO)"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:53:11Z","timestamp":1770655991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"alternative-id":["S2468294226000080"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101099","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatments and survival outcomes of patients with synchronous and metachronous metastatic bladder cancer: A population-based nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101099"}}